Related references
Note: Only part of the references are listed.PD-1 blockade exacerbates Mycobacterium tuberculosis infection in rhesus macaques
Keith D. Kauffman et al.
SCIENCE IMMUNOLOGY (2021)
Phase I/Ib Clinical Trial of Sabatolimab, an Anti-TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti-PD-1 Antibody, in Advanced Solid Tumors
Giuseppe Curigliano et al.
CLINICAL CANCER RESEARCH (2021)
TIM-3 in Leukemia; Immune Response and Beyond
Mahnaz Rezaei et al.
FRONTIERS IN ONCOLOGY (2021)
First-in-human phase I/Ib open-label dose-escalation study of GWN323 (anti-GITR) as a single agent and in combination with spartalizumab (anti-PD-1) in patients with advanced solid tumors and lymphomas
Sarina A. Piha-Paul et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Targeting Tim-3 in Cancer With Resistance to PD-1/PD-L1 Blockade
Tian Tian et al.
FRONTIERS IN ONCOLOGY (2021)
Mycobacterium abscessus Clearance by Neutrophils Is Independent of Autophagy
Kerstin Pohl et al.
INFECTION AND IMMUNITY (2020)
The Rise of Non-Tuberculosis Mycobacterial Lung Disease
Champa N. Ratnatunga et al.
FRONTIERS IN IMMUNOLOGY (2020)
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline: Executive Summary
Charles L. Daley et al.
CLINICAL INFECTIOUS DISEASES (2020)
Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitors
Kartik Anand et al.
ESMO OPEN (2020)
An immune checkpoint score system for prognostic evaluation and adjuvant chemotherapy selection in gastric cancer
Jia-Bin Wang et al.
NATURE COMMUNICATIONS (2020)
Potential of Immune-Related Genes as Biomarkers for Diagnosis and Subtype Classification of Preeclampsia
Ying Wang et al.
FRONTIERS IN GENETICS (2020)
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Daniela Bruni et al.
NATURE REVIEWS CANCER (2020)
TIM3 comes of age as an inhibitory receptor
Yochai Wolf et al.
NATURE REVIEWS IMMUNOLOGY (2020)
The immune checkpoint CD96 defines a distinct lymphocyte phenotype and is highly expressed on tumor-infiltrating T cells
Ailin Lepletier et al.
IMMUNOLOGY AND CELL BIOLOGY (2019)
Exploring immunomodulation by endocrine changes in Lady Windermere syndrome
M. R. Holt et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2019)
CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer
Laura M. McLane et al.
Annual Review of Immunology (2019)
Checkpoint Inhibition and Infectious Diseases: A Good Thing?
Michael S. Abers et al.
TRENDS IN MOLECULAR MEDICINE (2019)
Risk factors and secondary care utilisation in a primary care population with non-tuberculous mycobacterial disease in the UK
Eleanor L. Axson et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2019)
Whole-Blood Gene Expression in Pulmonary Nontuberculous Mycobacterial Infection
Steven A. Cowman et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2018)
Increasing nontuberculous mycobacteria reporting rates and species diversity identified in clinical laboratory reports
Maura J. Donohue
BMC INFECTIOUS DISEASES (2018)
High mortality in patients with Mycobacterium avium complex lung disease: a systematic review
Roland Diel et al.
BMC INFECTIOUS DISEASES (2018)
PD-L1, TIM-3, and CTLA-4 Blockade Fails To Promote Resistance to Secondary Infection with Virulent Strains of Toxoplasma gondii
Samantha D. Splitt et al.
INFECTION AND IMMUNITY (2018)
Neutrophil killing of Mycobacterium abscessus by intra- and extracellular mechanisms
Kenneth C. Malcolm et al.
PLOS ONE (2018)
Tim-3 co-stimulation promotes short-lived effector T cells, restricts memory precursors, and is dispensable for T cell exhaustion
Lyndsay Avery et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Anomalies in T Cell Function Are Associated With Individuals at Risk of Mycobacterium abscessus Complex Infection
Viviana P. Lutzky et al.
FRONTIERS IN IMMUNOLOGY (2018)
The cost of Mycobacterium avium complex lung disease in Canada, France, Germany, and the United Kingdom: a nationally representative observational study
S. M. Goring et al.
BMC HEALTH SERVICES RESEARCH (2018)
Immune checkpoint blockade in infectious diseases
Michelle N. Wykes et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Burden of non-tuberculous mycobacterial pulmonary disease in Germany
Roland Diel et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Markers of T Cell Senescence in Humans
Weili Xu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Attenuation of lymphocyte immune responses during Mycobacterium avium complex-induced lung disease due to increasing expression of programmed death-1 on lymphocytes
Chin-Chung Shu et al.
SCIENTIFIC REPORTS (2017)
Social network architecture of human immune cells unveiled by quantitative proteomics
Jan C. Rieckmann et al.
NATURE IMMUNOLOGY (2017)
The end of gating? An introduction to automated analysis of high dimensional cytometry data
Florian Mair et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
Update on pulmonary disease due to non-tuberculous mycobacteria
Jason E. Stout et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2016)
Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium
Josephine M. Bryant et al.
SCIENCE (2016)
Mining, visualizing and comparing multidimensional biomolecular data using the Genomics Data Miner (GMine) Web-Server7
Carla Proietti et al.
SCIENTIFIC REPORTS (2016)
Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease: Clinicians' Perspectives
Yon Ju Ryu et al.
TUBERCULOSIS AND RESPIRATORY DISEASES (2016)
Evaluating Robustness and Sensitivity of the NanoString Technologies nCounter Platform to Enable Multiplexed Gene Expression Analysis of Clinical Samples
Margaret H. Veldman-Jones et al.
CANCER RESEARCH (2015)
The Treatment of Rapidly Growing Mycobacterial Infections
Shannon H. Kasperbauer et al.
CLINICS IN CHEST MEDICINE (2015)
Epidemiology of Human Pulmonary Infection with Nontuberculous Mycobacteria A Review
D. Rebecca Prevots et al.
CLINICS IN CHEST MEDICINE (2015)
Binding of CXCL8/IL-8 to Mycobacterium tuberculosis Modulates the Innate Immune Response
Agnieszka Krupa et al.
MEDIATORS OF INFLAMMATION (2015)
Management of nontuberculous mycobacterial infection in the elderly
Mehdi Mirsaeidi et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2014)
Nontuberculous mycobacterial infections in children with inborn errors of the immune system
Margje H. Haverkamp et al.
JOURNAL OF INFECTION (2014)
Clonal Analysis of the T-Cell Response to In Vivo Expressed Mycobacterium tuberculosis Protein Rv2034, Using a CD154 Expression Based T-Cell Cloning Method
Susanna Commandeur et al.
PLOS ONE (2014)
The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples An NTM-NET collaborative study
Wouter Hoefsloot et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Occurrence of Nontuberculous Mycobacterial Pulmonary Infection in an Endemic Area of Tuberculosis
Ana Roberta Fusco da Costa et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
OMIP-014: Validated multifunctional characterization of antigen-specific human T cells by intracellular cytokine staining
Stephen C. De Rosa et al.
CYTOMETRY PART A (2012)
Blockade of Tim-3 signaling restores the virus-specific CD8+ T-cell response in patients with chronic hepatitis B
Wei Wu et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society
R. Mallone et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
SPICE: Exploration and Analysis of Post-Cytometric Complex Multivariate Datasets
Mario Roederer et al.
CYTOMETRY PART A (2011)
Elevated expression of Tim-3 on CD8 T cells correlates with disease severity of pulmonary tuberculosis
Xinjing Wang et al.
JOURNAL OF INFECTION (2011)
Mycobacterium abscessus Glycopeptidolipid Prevents Respiratory Epithelial TLR2 Signaling as Measured by HbD2 Gene Expression and IL-8 Release
Lisa B. Davidson et al.
PLOS ONE (2011)
Nontuberculous Pulmonary Mycobacteriosis in Denmark Incidence and Prognostic Factors
Claire Andrejak et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Increasing reports of non-tuberculous mycobacteria in England, Wales and Northern Ireland, 1995-2006
Jonathan E. Moore et al.
BMC PUBLIC HEALTH (2010)
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
Kaori Sakuishi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection
Hyun-Tak Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis
Eszter Lazar-Molnar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis
Javier O. Jurado et al.
JOURNAL OF IMMUNOLOGY (2008)
An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases
David E. Griffith et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles
PK Chattopadhyay et al.
NATURE MEDICINE (2005)